Gene transfer to salivary glands

International Review of Cytology

Volumn 213, Issue , 2002, Pages 93-146

  Baum, Bruce J ^a   Wellner, Robert B ^a   Zheng, Changyu ^a  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

Author keywords

Adenovirus; Biotechnology; Exocrine glands; Gene therapeutics; Gene therapy; Gene transfer; Salivary glands

Indexed keywords

ADENOVIRUS VECTOR;

BIOTECHNOLOGY; CHOLINERGIC TRANSMISSION; CYTOLOGY; DNA TRANSFER; GENE THERAPY; GENE TRANSFER; HORMONE RELEASE; HUMAN; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PRIORITY JOURNAL; PROTEIN SECRETION; REVIEW; SALIVARY GLAND; SIGNAL TRANSDUCTION; SYMPATHETIC TONE; VIRAL GENE DELIVERY SYSTEM;

ADENOVIRIDAE;

EID: 0036156213     PISSN: 00747696     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0074-7696(02)13013-0     Document Type: Chapter

References (231)

1. Immediate inflammatory responses to adenovirus-mediated gene transfer in rat salivary glands
2. The aquaporins, blueprints for cellular plumbing systems
3. Regulation of calcium in salivary gland secretion
4. Large-scale processing of recombinant retroviruses for gene therapy
5. Gene therapy and gene transfer clinical trials - Update. Part 1: Countries, diseases, clinical trial phases, routes of administration
6. Adenovirus type 37 uses sialic acid as a cellular receptor
7. Adenovirus-associated defective virus particles
8. Identification and characterization of beta-adrenergic receptors in rat parotid membranes
9. Cationic liposome-mediated gene transfer to rat salivary epithelial cells in vitro and in vivo
10. The effect of calcium and cyclic AMP on amylase release in digitonin-permeabilized parotid gland cells
11. The pathobiology of salivary gland. III. PCNA-localization of cycling cells induced in rat submandibular gland by low-dose x-radiation
12. Retrovirus-mediated gene transfer into salivary glands in vivo
13. Retrovirus-mediated gene transfer into rat salivary gland cells in vitro and in vivo
14. Neurotransmitter control of secretion
15. Principles of saliva secretion
16. In vivo gene transfer to salivary glands
17. Receptors in salivary glands
18. Polarized secretion of transgene products from salivary glands in vivo
19. Use of recombinant adenovirus for metabolic engineering of mammalian cells
20. Requirements for species-specific papovavirus DNA replication
21. Biology of adeno-associated virus
22. Serologic evidence for human infection with adenovirus-associated viruses
23. T lymphocyte-directed gene therapy for ADA-SCID: Initial, trial results after 4 years
24. Highly efficient and sustained gene transfer in adult neurons with a lentivirus vector
25. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: Polyethylenimine
26. Suppression of the immune response to an adenovirus vector and enhancement of intratumoral transgene expression by low-dose etoposide
27. Adenoassociated virus-mediated transfer of a functional water channel into salivary epithelial cells in vitro and in vivo
28. Biodistribution and transgene expression with nonviral cationic vector/DNA complexes in the lungs
29. Induction of apoptosis and G2/M arrest by infection with replication-deficient adenovirus at high multiplicity of infection
30. Adeno-associated viral vectors for gene transfer and gene therapy
31. HIV-1 nuclear import: In search of a leader
32. Herpes simplex virus types 1 and 2 completely help adenovirus-associated virus replication
33. Constitutive and regulated secretion of proteins
34. Adeno-associated viruses as gene delivery vehicles
35. Development of adeno-associated virus vectors for gene therapy of cystic fibrosis
36. Intracellular transport and secretion of salivary proteins
37. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease
38. Adeno-associated virus P5 promoter contains an adenovirus E1A-inducible element and a binding site for the major late transcription factor
39. Functional analysis of human tissue kallikrein in transgenic mouse models
40. SNARE-mediated membrane fusion
41. Integration of the adeno-associated virus genome into cellular DNA in latently infected human Detroit 6 cells
42. Biologically active Rep proteins of adeno-associated virus type 2 produced as fusion proteins in Escherichia coli
43. High-efficiency transfer of the T cell co-stimulatory molecule B7-2 to lymphoid cells using high-titer recombinant adeno-associated virus vectors
44. Cloning of adeno-associated virus type 4 (AAV4) and generation of recombinant AAV4 particles
45. Adeno-associated virus (AAV) type 5 Rep protein cleaves a unique terminal resolution site compared with other AAV serotypes
46. Cloning and characterization of adeno-associated virus type 5
47. Humoral immunity to adeno-associated virus type 2 vectors following administration to murine and nonhuman primate muscle
48. Structure of adenovirus complexed with its internalization receptor, alphavbeta5 integrin
49. A generic intron increases gene expression in transgenic mice
50. Regulated gene expression systems
51. Cationic lipid gene transfer of an IL-2 transgene leads to activation of natural killer cells in a SCID mouse human tumor xenograft
52. Oral azole drugs as systemic antifungal therapy
53. Secretion by the major salivary glands
54. Both M1 and M3 receptors regulate exocrine secretion by mucous acini
55. Evidence that M3 muscarinic receptors in rat parotid gland couple to two second messenger systems
56. Early events in the interaction of adenovimses with HeLa cells. IV. Association with microtubules and the nuclear pore complex during vectorial movement of the inoculum
57. Production of first generation adenovirus vectors: A review
58. Heparan sulfate glycosaminoglycans are involved in adenovirus type 5 and 2-host cell interactions
59. Adenovirusmediated expression of aquaporin-5 in epithelial cells
60. Increased fluid secretion after adenoviral-mediated transfer of the aquaporin-1 cDNA to irradiated rat salivary glands
61. Relationship between the cellular distribution of the alpha(v)beta3/5 integrins and adenoviral infection in salivary glands
62. Relationship between adenovirus-mediated aquaporin I expression and fluid movement across epithelial cells
63. DNA synthesis and cell division
64. Saliva and dental caries
65. Experimental infection of green monkeys with adenoassociated virus
66. Circular intermediates of recombinant adeno-associated virus have defined structural characteristics responsible for long-term episomal persistence in muscle tissue
67. Muscarinic receptor ligands and their therapeutic potential
68. pH-induced destabilization of phosphatidylethanolamine-containing liposomes: Role of bilayer contact
69. Stable in vivo gene transduction via a novel adenoviral/retroviral chimeric vector
70. Design and application of HSV vectors for neuroprotection
71. A novel adenovirus-adeno-associated virus hybrid vector that displays efficient rescue and delivery of the AAV genome
72. Expression of the cystic fibrosis transmembrane conductance regulator from a novel adeno-associated virus promoter
73. A phase I study of an adeno-associated virus-CFTR gene vector in adult CF patients with mild lung disease
74. A tetracycline controlled activation/repression system with increased potential for gene transfer into mammalian cells
75. Divergence and convergence in regulated exocytosis: The characteristics of cAMP-dependent enzyme secretion of parotid salivary acinar cells
76. Vesicle-associated membrane protein 2 is essential for cAMP-regulated exocytosis in rat parotid acinar cells. The inhibition of cAMP-dependent amylase release by botulinum neurotoxin B
77. Snare proteins essential for cyclic AMP-regulated exocytosis in salivary glands
78. High-titer adeno-associated viral vectors from a Rep/Cap cell line and hybrid shuttle virus
79. Influences of secretory activities in rat submandibular glands on tissue kallikrein circulating in the blood
80. Transient expression of genes transferred in vivo into heart using first-generation adenoviral vectors: Role of the immune response
81. The endocrine secretion of human insulin and growth hormone by exocrine glands of the gastrointestinal tract
82. Stepwise dismantling of adenovirus 2 during entry into cells
83. Identification of TIAR as a protein binding to the translational regulatory AU-rich element of tumor necrosis factor alpha mRNA
84. Gene therapy using adenovirus vectors
85. Development of biomaterials for gene therapy
86. Salivary glands
87. Frequency and stability of chromosomal integration of adenovirus vectors
88. Host responses and persistence of vector genome following intrabronchial administration of an Ei(-)E3(-) adenovirus gene transfer vector to normal individuals
89. A simplified system for generating recombinant adenoviruses
90. Polarized distribution of key membrane transport proteins in the rat submandibular gland
91. Systemic action of human growth hormone following adenovirus-mediated gene transfer to rat submandibular glands
92. Studies of small DNA viruses found in various adenovirus preparations: Physical, biological, and immunological characteristics
93. Construction and function of a recombinant adenovirus encoding a human aquaporin 1-green fluorescent protein fusion product
94. Mutational analysis of adeno-associated virus Rep protein-mediated inhibition of heterologous and promoters
95. Viral entry and receptors
96. The endocrine secretion of mammalian digestive enzymes by exocrine glands
97. + release from rat parotic cells: An alpha 1-adrenergic mediated event
98. Efficient synthesis of adeno-associated virus structural proteins requires both adenovirus DNA binding protein and VA I RNA
99. Transduction of dendritic cells by DNA viral vectors directs the immune response to transgene products in muscle fibers
100. Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors
101. Evidence for the systemic delivery of a transgene product from salivary glands
102. Repetitive adenovirus administration to the parotid gland: Role of immunological barriers and induction of oral tolerance
103. Epstein-Barr virus: Mechanisms of oncogenesis
104. Viral vectors for gene therapy: The art of turning infectious agents into vehicles of therapeutics
105. Pathways of protein secretion in eukaryotes
106. Aquaporins in health and disease
107. Epstein-Barr virus strategy in normal and neoplastic B cells
108. High-capacity adenoviral vectors for gene transfer and somatic gene therapy
109. Characterization of a preferred site on human chromsome 19q for integration of adeno-associated virus DNA by non-homologous recombination
110. Molecular cloning of a new aquaporin from rat pancreas and liver
111. Genetic targeting of adenoviral vectors
112. Analysis of adeno-associated virus (AAV) wild-type and mutant Rep proteins for their abilities to negatively regulate AAV p5 and p19 mRNA levels
113. Pilot study comparing the salivary cationic protein concentrations in healthy adults and AIDS patients: Correlation with antifungal activity
114. Herpes virus vectors for gene therapy in the nervous system
115. Effect of deletions in adenovirus early region 1 genes upon replication of adeno-associated virus
116. A cassette for high-level expression in the mouse salivary glands
117. Salivary gland hyperglycemic factor: An extrapancreatic source of glucagon-like material
118. Physiological factors affecting secretion of parotid hormone
119. Adenovirus E1A proteins interact with the cellular YY1 transcription factor
120. Examination of rat salivary glands for the presence of the aquaporin CHIP
121. Integrating adenovirus-adeno-associated virus hybrid vectors devoid of all viral genes
122. In human salivary gland cells, overexpression of E2F1 overcomes an interferon-gamma- and tumor necrosis factor-alpha-induced growth arrest but does not result in complete mitosis
123. Involvement of nuclear orphan receptor (NGFI-B in transcriptional activation of salivary-specific R15 gene by cAMP
124. Construction of new retroviral producer cells from adenoviral and retroviral vectors
125. 2+ influx mechanism in salivary gland cells
126. Production of recombinant adeno-associated virus vectors using a packaging cell line and a hybrid recombinant adenovirus
127. Defective secretion of saliva in transgenic mice lacking aquaporin-5 water channels
128. Non-viral peptide-based approaches to gene delivery
129. Pharmaceutical perspectives of nonviral gene therapy
130. The functions of saliva
131. The role of saliva in maintaining oral homeostasis
132. Direct in vivo adenovirus-mediated gene transfer to salivary glands
133. Interaction of the adeno-associated virus Rep protein with a sequence within the A palindrome of the viral terminal repeat
134. Adeno-associated virus general transduction vectors: Analysis of proviral structures
135. Replication of plasmids derived from bovine papilloma virus type 1 and Epstein-Barr virus in cells in culture
136. Chloride channels and salivary gland function
137. The kinetics of rAAV integration in the liver
138. Common mechanisms for regulated exocytosis in the chromaffin cell and the synapse
139. In vivo gene electroporation confers nutritionally-regulated foreign gene expression in the liver
140. Use of adeno-associated virus as a general transduction vector for mammalian cells
141. Construction and analysis of simian virus 40 origins defective in tumor antigen binding and DNA replication
142. Inhibition of salivary fluid secretion by occlusion of the intercellular space
143. Increasing the size of rAAV-mediated expression cassettes in vivo by intermolecular joining of two complementary vectors
144. Quantitative microscopy of fluorescent adenovirus entry
145. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector
146. Regulation of electrolyte and fluid secretion in salivary acinar cells
147. Cell receptors involved in adenovirus entry
148. Aquaporins in complex tissues. II. Subcellular distribution in-respiratory and glandular tissues of rat
149. Facilitated DNA transfer to rat submandibular gland in vivo and GRP-Ca gene regulation
150. Transfer of a gene encoding the anticandidal protein histatin 3 to salivary glands
151. Nonspecific inflammation inhibits adenovirus-mediated pulmonary gene transfer and expression independent of specific acquired immune responses
152. Identification of a DNA-binding domain in the amino terminus of adeno-associated virus Rep proteins
153. Heterologous introns can enhance expression of transgenes in mice
154. Progress with retroviral gene vectors
155. Hepatic gene therapy using adeno-associated virus vectors
156. The adeno-associated virus (AAV) Rep protein acts as both a repressor and an activator to regulate AAV transcription during a productive infection
157. The cytology of salivary glands
158. Alpha- and beta-adrenergic receptors of the rat salivary gland. Elevation after chemical sympathectomy
159. Simulus-exocytosis coupling mechanism in salivary gland cells
160. Signal transduction mechanisms involved in salivary gland regulated exocytosis
161. Molecular cloning and characterization of an aquaporin cDNA from salivary, lacrimal, and respiratory tissues
162. Adenovirus vectors as transcomplementing templates for the production of replication defective retroviral vectors
163. Site-specific integration mediated by a hybrid adenovirus/adeno-associated virus vector
164. Proliferative activity by cell type in the developing rat parotid gland
165. Identification of a protein linked to the ends of adenovirus DNA
166. Regulation of protein secretion through controlled aggregation in the endoplasmic reticulum
167. Efficient and regulated erythropoietin production by naked DNA injection and muscle electroporation
168. The replication of herpesviruses
169. Herpes simplex viruses and their replication
170. In vivo electrically mediated protein and gene transfer in murine melanoma
171. Persistence and expression of the herpes simplex virus genome in the absence of immediate-early proteins
172. Adeno-associated virus: Integration at a specific chromosomal locus
173. Adenovirus E1B 55-Mr polypeptide facilitates timely cytoplasmic accumulation of adeno-associated virus mRNAs
174. A recombinant plasmid from which an infectious adeno-associated virus genome can be excised in vitro and its use to study viral replication
175. Safety and short-term toxicity of a novel cationic lipid formulation for human gene therapy
176. Adeno-associated virus (AAV) Rep protein enhances the generation of a recombinant mini-adenovirus (Ad) utilizing an Ad/AAV hybrid virus
177. Involvement of G alpha q/11 in m3-muscarinic receptor stimulation of phosphatidylinositol 4,5 bisphosphate-specific phospholipase C in rat parotid gland membranes
178. Salivary secretion of electrolytes
179. Adenovirol vectors
180. Adenovidae: The viruses and their replication
181. The role of immune mechanisms in control of herpes simplex virus infection of the peripheral nervous system
182. 2+ influx in salivary gland fluid secretion
183. The Rep52 gene product of adeno-associated virus is a DNA helicase with 3′-to-5′ polarity
184. The Rep78 gene product of adeno-associated virus (AAV) self-associates to form a hexameric complex in the presence of AAV ori sequences
185. Adeno-associated virus-mediated gene delivery
186. In vitro resolution of covalently joined AAV chromosome ends
187. Features of the adeno-associated virus origin involved in substrate recognition by the viral Rep protein
188. Nucleotide sequence and organization of the adeno-associated virus 2 genome
189. Abnormal distribution of aquaporin-5 water channel protein in salivary glands from Sjogren's syndrome patients
190. Water permeability of acinar cell membranes in the isolated perfused rabbit mandibular salivary gland
191. Gene therapy using SV40-derived vectors: What does the fulure hold
192. Gene delivery to the liver using simian virus 40-derived vectors
193. Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions
194. Microtubule-dependent plus- and minus end-directed motilities are competing processes for nuclear targeting of adenovirus
195. Retrovirus vectors
196. Evidence for the putative docking/fusion complex of exocytosis in parotid acinar cells
197. Interaction of SNARE proteins in rat parotid acinar cells
198. Adeno-associated virus-based vectors in gene therapy
199. Salivary glands and the secretory process
200. Endogenous retroviral sequences are required for tissue-specific expression of a human salivary amylase gene
201. Two separable functional domains of simian virus 40 large T antigen: Carboxy-terminal region of simian virus 40 large T antigen is required for efficient capsid protein synthesis
202. Ion transport related to fluid secretion in salivary glands
203. Mechanisms of fluid secretion by salivary glands
204. Ion and water transport mechanisms in salivary glands
205. Lentiviral vectors: Excellent tools for experimental gene transfer and promising candidates for gene therapy
206. Expression of human tissue kallikrein in rat salivary glands and its secretion into circulation following adenovirus-mediated gene transfer
207. Effect of clodronate on macrophage depletion and adenoviral-mediated transgene expression in salivary glands
208. Adenoviral-mediated gene transfer to mouse salivary glands
209. Identification of muscarinic receptor subtypes in mouse parotid gland
210. Adeno-associated virus (AAV) Rep proteins mediate complex formation between AAV DNA and its integration site in human DNA
211. Evidence that aquaporin-8 is located in the basolateral membrane of rat submandibular gland acinar cells
212. Recombinant, replication-defective adenovirus gene transfer vectors induce cell cycle dysregulation and inappropriate expression of cyclin proteins
213. Introduction of foreign genes into tissues of living mice by DNA-coated microprojectiles
214. Immunomodulation to enhance gene therapy
215. E3 transcription unit of adenovirus
216. Enhancement of in vivo adenovirus-mediated gene transfer and expression by prior depletion of tissue macrophages in the target organ
217. A history of gene transfer and therapy
218. An early history of gene transfer and therapy
219. Direct gene transfer into mouse muscle in vivo
220. Macrophages and other nonspecific defenses: Role in modulating resistance against herpes simplex virus
221. Production of viral vectors for gene therapy applications
222. From the cover: Transsplicing vectors expand the utility of adeno-associated virus for gene therapy
223. In vivo and in vitro gene transfer to mammalian somatic cells by particle bombardment
224. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses
225. Recombinant IL-12 prevents formation of blocking IgA antibodies to recombinant adenovirus and allows repeated gene therapy to mouse lung
226. Role of viral antigens in destructive cellular immune responses to adenovirus vector-transduced cells in mouse lungs
227. Interaction between the calcium and cyclic AMP messenger systems in perifused rat parotid acinar cells. Possible mechanism for potentiation of amylase secretion
228. The streaming submandibular gland
229. Genomic integration and gene expression by a modified adenoviral vector
230. Adenoviral vector cytotoxicity depends in part on the transgene encoded